{{chemref|time=2017-12-24T17:52:04+00:00}}
{{expand|time=2015-09-04T17:07:25+00:00}}
{{medical}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470629155
| IUPAC_name = 7,8,9,10-Tetrahydro-6,10-methano-6''H''-pyrazino[2,3-h] [3]benzazepine
| image = Varenicline.svg
| width = 155
<!--Clinical data-->
| tradename = 畅沛、戒必適、Chantix、Chanpix
| Drugs.com = {{drugs.com|monograph|chantix}}
| MedlinePlus = a606024
| licence_EU = Champix
| licence_US = Varenicline
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| dependency_liability = 
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = <20%
| metabolism = 有限 (<10%)
| elimination_half-life = 24 小时
| excretion = [[肾脏|肾脏]] (81–92%)
<!--Identifiers-->
| IUPHAR_ligand = 5459
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 249296-44-4
| CAS_number2 = 375815-87-5
| ATC_prefix = N07
| ATC_suffix = BA03
| ATC_supplemental = 
| PubChem = 5310966
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01273
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4470510

| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W6HS99O8ZO
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1076903
| KEGG = D08669
| KEGG_Ref = {{keggcite|changed|kegg}}
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 84500
<!--Chemical data-->
| C=13 | H=13 | N=3
| molecular_weight = 211.267 g/mol
| smiles = n1c2cc3c(cc2ncc1)[C@@H]4CNC[C@H]3C4
| InChI = 1/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2/t8-,9+
| InChIKey = JQSHBVHOMNKWFT-DTORHVGOBF
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2/t8-,9+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JQSHBVHOMNKWFT-DTORHVGOSA-N
}}

'''伐尼克兰'''（{{lang-en|Varenicline}}） ，中文商品名为'''畅沛'''（中國大陸）、'''戒必適'''（臺灣），由[[辉瑞制药|辉瑞制药]]研发和销售，是一种用来治疗[[尼古丁依赖|尼古丁依赖]]的[[处方药|处方药]]。<!--TRANSLATING...
is a prescription medication used to treat [[nicotine|nicotine]] addiction. Varenicline is a [[nicotinic_receptor|nicotinic receptor]] [[partial_agonist|partial agonist]]—it stimulates nicotine receptors more weakly than [[nicotine|nicotine]] itself does. In this respect it is similar to [[cytisine|cytisine]] and different from the [[Receptor_antagonist|nicotinic antagonist]], [[bupropion|bupropion]], and [[nicotine_replacement_therapy|nicotine replacement therapies]] (NRTs) like [[nicotine_patch|nicotine patch]]es and [[nicotine_gum|nicotine gum]]. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms it can assist some patients to quit smoking.-->

[[Category:戒烟|Category:戒烟]]
[[Category:辉瑞|Category:辉瑞]]
[[Category:桥环杂环化合物|Category:桥环杂环化合物]]
[[Category:吡嗪|Category:吡嗪]]